(R)-N-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)picolinamide

ID: ALA551051

Cas Number: 827591-02-6

PubChem CID: 11416123

Max Phase: Preclinical

Molecular Formula: C18H16ClN3O

Molecular Weight: 325.80

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1

Standard InChI:  InChI=1S/C18H16ClN3O/c19-11-7-8-14-13(10-11)12-4-3-6-15(17(12)21-14)22-18(23)16-5-1-2-9-20-16/h1-2,5,7-10,15,21H,3-4,6H2,(H,22,23)/t15-/m1/s1

Standard InChI Key:  WJQBOBGVBBZLJU-OAHLLOKOSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -4.3018    3.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0163    3.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0163    2.5045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3018    2.0920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5873    2.5045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5873    3.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8027    2.2495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3178    2.9170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8027    3.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4671    4.3381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6466    4.4243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1617    3.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4973    3.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0124    2.3358    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1874    2.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2251    1.6213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2251    3.0502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1874    0.9068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2251    0.1923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0501    0.1923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4627    0.9068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0502    1.6213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7308    3.7420    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  7  1  0
  6  5  1  0
  6  9  1  0
  7  8  1  0
 13  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 22  2  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
  2 23  1  0
M  END

Associated Targets(Human)

HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DHODH Tclin Dihydroorotate dehydrogenase (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human papillomavirus type 16 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dengue virus (413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 325.80Molecular Weight (Monoisotopic): 325.0982AlogP: 4.02#Rotatable Bonds: 2
Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.48CX Basic pKa: 2.10CX LogP: 3.55CX LogD: 3.55
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.07

References

1. Gudmundsson KS, Boggs SD, Sebahar PR, Richardson LD, Spaltenstein A, Golden P, Sethna PB, Brown KW, Moniri K, Harvey R, Romines KR..  (2009)  Tetrahydrocarbazole amides with potent activity against human papillomaviruses.,  19  (15): [PMID:19556128] [10.1016/j.bmcl.2009.06.001]
2. Okesli-Armlovich A, Gupta A, Jimenez M, Auld D, Liu Q, Bassik MC, Khosla C..  (2019)  Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.,  29  (18): [PMID:31420268] [10.1016/j.bmcl.2019.08.010]
3. Boschi D, Pippione AC, Sainas S, Lolli ML..  (2019)  Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.,  183  [PMID:31557612] [10.1016/j.ejmech.2019.111681]

Source